Andersen R, Wulff Westergaard MC, Westerlin Kjeldsen J, Mueller A, Wulff Pedersen N, Reker Hadrup S, Met O, Seliger B, Kromann-Andersen B, Hasselager T, Donia M, Svane IM. T cell responses in the microenvironment of primary renal cell carcinoma - Implications for adoptive cell therapy. Cancer Immunol Res. 2018 Jan 4. pii: canimm.0467.2017. doi: 10.1158/2326-6066.CIR-17-0467. [Epub ahead of print]


Glasner A, Levi A, Enk J, Isaacson B, Viukov S, Orlanski S, Scope A, Neuman T, Enk CD, Hanna JH, Sexl V, Jonjic S, Seliger B, Zitvogel L, Mandelboim O. NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis. Immunity. 2018 Jan 4. pii: S1074-7613(17)30536-8. doi: 10.1016/j.immuni.2017.12.007. [Epub ahead of print]


Subbarayan K, Leisz S, Wickenhauser C, Bethmann D, Massa C, Steven A, Seliger B. Biglycan-mediated upregulation of MHC class I expression in HER-2/neu-transformed cells. Oncoimmunology. 2018 Jan 16;7(4):e1373233. doi: 10.1080/2162402X.2017.1373233.


in press:

Steven A., Seliger B. The Role of Immune Escape and Immune Cell Infiltration in Breast Cancer. Breast Care 2018;13:16-21 (DOI:10.1159/000486585)